Pascal Bonnier
About
In The Last Decade
Pascal Bonnier
89 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 109
- Oncology 1.4k
- Cancer Research 1.1k
- Molecular Biology 895
- Pathology and Forensic Medicine 495
- Genetics 331
Countries citing papers authored by Pascal Bonnier
This map shows the geographic impact of Pascal Bonnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Bonnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Bonnier more than expected).
Fields of papers citing papers by Pascal Bonnier
This network shows the impact of papers produced by Pascal Bonnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Bonnier. The network helps show where Pascal Bonnier may publish in the future.
Co-authorship network of co-authors of Pascal Bonnier
This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Bonnier. A scholar is included among the top collaborators of Pascal Bonnier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Bonnier. Pascal Bonnier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 2 | |
| 3 | 7 | |
| 4 | 10 | |
| 5 | 47 | |
| 6 | 62 | |
| 7 | 2 | |
| 8 | 18 | |
| 9 | 18 | |
| 10 | 4 | |
| 11 | 4 | |
| 12 | 16 | |
| 13 | 50 | |
| 14 | 46 | |
| 15 | 12 | |
| 16 | 85 | |
| 17 | 44 | |
| 18 | 1 | |
| 19 | 7 | |
| 20 | Inflammatory breast carcinoma: an immunohistochemical study using monoclonal anti-pHER-2/neu, pS2, cathepsin, ER and PR. | 37 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.